Cargando…
Knockdown of KLK11 inhibits cell proliferation and increases oxaliplatin sensitivity in human colorectal cancer
It has been reported that kallikrein 11 (KLK11) is crucially involved in the development and progression of various types of cancer. However, the molecular mechanisms that underlie the involvement of KLK11 in aberrant colorectal cancer (CRC) cell growth remain largely unclear. The aim of the present...
Autores principales: | Xu, Zongbin, Chi, Pan, Pan, Jie, Shen, Songfei, Sun, Yanwu, Wang, Xiaojie, Lu, Xingrong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5103714/ https://www.ncbi.nlm.nih.gov/pubmed/27882085 http://dx.doi.org/10.3892/etm.2016.3723 |
Ejemplares similares
-
Knockdown of KLK11 reverses oxaliplatin resistance by inhibiting proliferation and activating apoptosis via suppressing the PI3K/AKT signal pathway in colorectal cancer cell
por: Zhang, Yiyi, et al.
Publicado: (2018) -
FBXW4 Acts as a Protector of FOLFOX-Based Chemotherapy in Metastatic Colorectal Cancer Identified by Co-Expression Network Analysis
por: Zhang, Yiyi, et al.
Publicado: (2020) -
A nomogram predicting pathological complete response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer: implications for organ preservation strategies
por: Sun, Yanwu, et al.
Publicado: (2017) -
Identification of LncRNAs Associated With FOLFOX Chemoresistance in mCRC and Construction of a Predictive Model
por: Zhang, Yiyi, et al.
Publicado: (2021) -
Knockdown of KLK12 inhibits viability and induces apoptosis in human colorectal cancer HT-29 cell line
por: Li, Qianyuan, et al.
Publicado: (2019)